Rankings
▼
Calendar
IART FY 2021 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$738M
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.5B
+12.4% YoY
Gross Profit
$945M
61.2% margin
Operating Income
$197M
12.8% margin
Net Income
$169M
11.0% margin
EPS (Diluted)
$1.98
Cash Flow
Operating Cash Flow
$312M
Free Cash Flow
$264M
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$3.8B
Total Liabilities
$2.1B
Stockholders' Equity
$1.7B
Cash & Equivalents
$513M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.5B
$1.4B
+12.4%
Gross Profit
$945M
$851M
+11.0%
Operating Income
$197M
$151M
+30.3%
Net Income
$169M
$134M
+26.3%
← Q4 2020
All Quarters
Q1 2021 →